| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8813565 | Pediatrics & Neonatology | 2016 | 6 Pages |
Abstract
Entecavir for pediatric CHB treatment is safe and shows clinical benefits in short-term biochemical and virologic responses. Further studies to determine long-term remission and drug resistance are required.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Kai-Chi Chang, Jia-Feng Wu, Hong-Yuan Hsu, Huey-Ling Chen, Yen-Hsuan Ni, Mei-Hwei Chang,